Concepts for Analgosedation During Placement of Regional Anaesthesia Before Operations.

NCT ID: NCT04026074

Last Updated: 2019-10-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-07-26

Study Completion Date

2019-10-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Aim of the study is to specify the best analgosedation technique during placement of regional anaesthesia from the patients' view.

In this double blind randomized trial the investigators will be testing the application of drugs administered intravenously (fentanyl-bolus, remifentanil-infusion, clonidine-bolus) or transcutaneously (EMLA salve) or placebo (NaCl 0,9% i.v. and skin protection salve).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this doubleblind randomized pilot trial, patients will receive one of five possible combinations to assess which medication leads to the best medication during placement of regional anaesthesia. This assessement includes NRS, patients' satisfaction and wellbeing. The tested substances will be administered intravenously (fentanyl-bolus, remifentanil-infusion, clonidine-bolus) or transcutaneously (EMLA salve). The fifth combination will be the control group with only placebo medication. We expected to get first information for objectifying analgosedation during placement of regional anaesthesia for the conduction of further studies in this field.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Knee Arthropathy Hip Arthritis Fractures, Closed

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Fentanyl i.v. (intravenously)

Patients will be administered the medication and additionally will be treated with placebo salve (skin protection salve)

Group Type EXPERIMENTAL

Fentanyl

Intervention Type DRUG

Weight adapted drug application

Placebo salve

Intervention Type DRUG

Skin protection salve (placebo salve) application on the body part where the regional anaesthesia will be administered

Remifentanil i.v.

Patients will be administered the medication and additionally will be treated with placebo salve (skin protection salve)

Group Type EXPERIMENTAL

Remifentanil

Intervention Type DRUG

Weight adapted drug application

Placebo salve

Intervention Type DRUG

Skin protection salve (placebo salve) application on the body part where the regional anaesthesia will be administered

Clonidine i.v.

Patients will be administered the medication and additionally will be treated with placebo salve (skin protection salve)

Group Type EXPERIMENTAL

Clonidine

Intervention Type DRUG

Weight adapted drug application

Placebo salve

Intervention Type DRUG

Skin protection salve (placebo salve) application on the body part where the regional anaesthesia will be administered

EMLA salve

Patients will be administered the medication (salve) and additionally will be administered i.v. saline as placebo

Group Type EXPERIMENTAL

EMLA Cream

Intervention Type DRUG

Salve application on the body part where the regional anaesthesia will be administered

Placebo iv

Intervention Type DRUG

i.v. administration of 0,9% NaCl

Placebo

Patients will be administered i.v. placebo (0,9% NaCl) and placebo salve (skin protection salve)

Group Type PLACEBO_COMPARATOR

Placebo iv

Intervention Type DRUG

i.v. administration of 0,9% NaCl

Placebo salve

Intervention Type DRUG

Skin protection salve (placebo salve) application on the body part where the regional anaesthesia will be administered

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Fentanyl

Weight adapted drug application

Intervention Type DRUG

Remifentanil

Weight adapted drug application

Intervention Type DRUG

Clonidine

Weight adapted drug application

Intervention Type DRUG

EMLA Cream

Salve application on the body part where the regional anaesthesia will be administered

Intervention Type DRUG

Placebo iv

i.v. administration of 0,9% NaCl

Intervention Type DRUG

Placebo salve

Skin protection salve (placebo salve) application on the body part where the regional anaesthesia will be administered

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients planed electively for orthopedic surgery

Exclusion Criteria

* Missing patient's consent
* Intolerance against study medication
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical University of Graz

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gregor A Schittek, MD

Role: PRINCIPAL_INVESTIGATOR

Medical University of Graz

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medical University Hospital LKH Graz

Graz, , Austria

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.